Utilizing drug-drug interaction prediction tools during drug development: enhanced decision making based on clinical risk.

Autor: Shardlow CE; Department of Drug Metabolism and Pharmacokinetics, GlaxoSmithKline, PTS DMPK, Park Road, Ware, Herts, United Kingdom SG12 0DP. Carole.E.Shardlow@gsk.com, Generaux GT, MacLauchlin CC, Pons N, Skordos KW, Bloomer JC

Publikováno v: Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2011 Nov; Vol. 39 (11), pp. 2076-84. Date of Electronic Publication: 2011 Aug 10.